Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wellbeing Digital Sciences Inc (OP: KONEF ) N/A UNCHANGED Last Price Updated: 3:57 PM EST, Mar 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Wellbeing Digital Sciences Inc < Previous 1 2 3 Next > Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project December 06, 2022 Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... Via Benzinga Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response December 06, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial November 30, 2022 Psychedelics biotechs Nova Mentis Life Science Corp. (OTCQB: NMLSF) and Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Sciences Inc. Via Benzinga Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial November 30, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary Mindscape Treats its 1,000th Patient November 29, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors November 22, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More November 21, 2022 Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy Via Benzinga Wellbeing Digital Announces Resignation of Directors November 18, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial November 17, 2022 Psychedelics company Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Science Inc. has entered into a research services agreement with Canadian-based biotech Nova Mentis Life Science... Via Benzinga Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial November 17, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Successful Study On Transdermal CBD & THC Delivery Presents Benefits For Treating Chronic Conditions November 15, 2022 Wellbeing Digital Sciences Inc. (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company announced that its wholl Via Benzinga Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers November 14, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Subsidiary KGK to Participate in Microdose Wonderland Miami Conference November 02, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More November 01, 2022 15 Global Psychedelics Executives To Keep An Eye On In 2022 Via Benzinga Pathway Health To Acquire IRP Health From Wellbeing Digital Sciences October 27, 2022 Wellbeing Digital Sciences Inc. Via Benzinga Wellbeing Announces Definitive Agreement to Divest IRP Health October 27, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate at this Years’ Wonderland Miami Conference October 25, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Subsidiary KGK to Participate in the Supply Side West Conference October 13, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital and Subsidiary KGK Science Applauds the Government of Alberta’s Move to Regulate the Use of Psychedelics October 11, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More October 07, 2022 Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy Via Benzinga Wellbeing Subsidiary KGK Science Announces Psilocybin Microdose Capsule Formulation to be Submitted to Health Canada for Phase 2A Trial October 06, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option October 05, 2022 Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S. Via Benzinga Wellbeing Digital to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics September 29, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Signs LOI Manage Additional Clinics October 04, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Opens New Clinical Research Center to Reimagine a Healthier Future September 26, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate in the Microdose Psychedelic Capital Conference September 23, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Reports 4Q Finances, 'Three Key Pillars' Stay Strong September 16, 2022 Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period... Via Benzinga Wellbeing Digital Reports Financial Results for the Fourth Fiscal Quarter September 15, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga Wellbeing’ CEO Joins Benzinga’s Psychedelic Advisory Board August 30, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.